Under a settlement with the Federal Trade Commission, a software vendor has agreed to pay $150,000 to the FTC and to stop making deceptive health claims that its app can improve users’ vision.

Calabasas, Calif.-based Carrot Neurotechnology Inc. and its co-owners are required to have “competent and reliable scientific evidence” before making vision claims for its Ultimeyes app and similar products, or claims regarding the health benefits, performance, efficacy, safety, or side effects of any product or service.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access